Cardiovascular Complications Associated With Primary Aldosteronism: A Controlled Cross-Sectional Study

Recommendations for Chamber Quantification: A Report from the American Society of Echocardiography’s Guidelines and Standards Committee and the Chamber Quantification Writing Group, Developed in Conjunction with the European Association of Echocardiography, a Branch of the European Society of Cardiology

Lang, R. M., Bierig, M., Devereux, R. B., Flachskampf, F. A., Foster, E., Pellikka, P. A., Picard, M. H., Roman, M. J., Seward, J., Shanewise, J. S., et al. (2005) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2005.10.005 · Cited by 11,318

Heart Disease and Stroke Statistics—2012 Update: A Report From the American Heart Association

Writing Group Members, Roger, V. L., Go, A. S., Lloyd-Jones, D. M., Benjamin, E. J., Berry, J. D., Borden, W. B., Bravata, D. M., Dai, S., Ford, E. S., et al. (2012) · Circulation · doi:10.1161/cir.0b013e31823ac046 · Cited by 7,333

Universal Definition of Myocardial Infarction

Thygesen, K. A., Alpert, J. S., White, H. D., TASK FORCE MEMBERS: Chairpersons: Kristian Thygesen (Denmark), J. S. A. (., Biomarker Group: Allan S. Jaffe, C. (., ECG Group: Bernard Chaitman, C.-O. (., Imaging Group: Richard Underwood, C. (., Intervention Group: Jean-Pierre Bassand, C.-O. (., Mendis, S., Implementation Group: Lars C. Wallentin Coordinator (Sweden), F. F.-A. (., et al. (2007) · Circulation · doi:10.1161/circulationaha.107.187397 · Cited by 4,422

Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction. Universal definition of myocardial infarction

Thygesen, K. A. (2007) · Circulation · Cited by 3,126

ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): Developed in Collaboration With the European Heart Rhythm Association and the Heart Rhythm Society

Fuster, V., Rydén, L. E., Cannom, D. S., Crijns, H. J., Curtis, A. B., Ellenbogen, K. A., Halperin, J. L., Le Heuzey, J.-Y., Kay, G. N., Lowe, J. E., et al. (2006) · Circulation · doi:10.1161/circulationaha.106.177292 · Cited by 2,805

The ventricular complex in left ventricular hypertrophy as obtained by unipolar precordial and limb leads

Sokolow, M., & Lyon, T. P. (1949) · American Heart Journal · doi:10.1016/0002-8703(49)90562-1 · Cited by 1,990

Untitled work

(2000) · Journal of the American Society of Nephrology · Cited by 1,718

Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism

Milliez, P., Girerd, X. J., Plouin, P., Blacher, J., Safar, M. E., & Mourad, J. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.01.015 · Cited by 1,541

Effect of growth on variability of left ventricular mass: Assessment of allometric signals in adults and children and their capacity to predict cardiovascular risk

SIMONE, G. D., Devereux, R. B., Daniels, S. R., Koren, M. J., Meyer, R. A., & Laragh, J. H. (1995) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(94)00540-7 · Cited by 900

Oxford textbook of clinical nephrology

Cameron, S. M. (2013) · Oxford University Press eBooks · Cited by 717

Fully automated chemiluminescence vs RIA aldosterone assay in primary aldosteronism work-up

Pizzolo, F., Salvagno, G. L., Caruso, B., Cocco, C., Zorzi, F., Zaltron, C., Castagna, A., Bertolone, L., Morandini, F., Lippi, G., et al. (2017) · Journal of Human Hypertension · doi:10.1038/jhh.2017.62 · Cited by 18

Treatment of Unilateral PA by Adrenalectomy: Potential Reasons for Incomplete Biochemical Cure

Yang, Y., Reincke, M., & Williams, T. A. (2018) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/a-0662-6081 · Cited by 17

Colocalization of Wnt/β-Catenin and ACTH Signaling Pathways and Paracrine Regulation in Aldosterone-producing Adenoma

Sousa, K. D., Abdellatif, A. B., Giscos-Douriez, I., Méatchi, T., Amar, L., Fernandes-Rosa, F. L., Boulkroun, S., & Zennaro, M. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab707 · Cited by 17

Adrenal Vein Sampling: Tips and Tricks

Kobayashi, K., Alkukhun, L., Rey, E., Salaskar, A. L., & Acharya, R. (2024) · Radiographics · doi:10.1148/rg.230115 · Cited by 17

PROGRESS IN PRIMARY ALDOSTERONISM: Mineralocorticoid antagonist treatment for aldosterone-producing adenoma

Amar, L., Lorthioir, A., Azizi, M., & Plouin, P. (2014) · European Journal of Endocrinology · doi:10.1530/eje-14-0585 · Cited by 17

New Advances in the Diagnostic Workup of Primary Aldosteronism

Wolley, M. J., & Stowasser, M. (2017) · Journal of the Endocrine Society · doi:10.1210/js.2016-1107 · Cited by 17

Aldosterone level after saline infusion test could predict clinical outcome in primary aldosteronism after adrenalectomy

Chan, C., Kim, J. H., Chueh, E., Chang, C., Lin, Y., Lai, T., Huang, K., Lin, Y., & Wu, V. (2019) · Surgery · doi:10.1016/j.surg.2019.05.001 · Cited by 17

What Is the Most Common Cause of Secondary Hypertension?: An Interdisciplinary Discussion

Almeida, M. Q., da Silva, G. V., & Drager, L. F. (2020) · Current Hypertension Reports · doi:10.1007/s11906-020-01106-5 · Cited by 40

Primary aldosteronism and thyroid disorders in atrial fibrillation: A Swedish nationwide case–control study

Mourtzinis, G., Eryd, S. A., Rosengren, A., Bjorck, L. M., Adiels, M., Johannsson, G., & Manhem, K. (2018) · European Journal of Preventive Cardiology · doi:10.1177/2047487318759853 · Cited by 17

Primary Aldosteronism More Prevalent in Patients With Cardioembolic Stroke and Atrial Fibrillation

Nguyen, V. A. T., Tu, T. M., Mamauag, M. J., Lai, J., Saffari, S. E., Aw, T. C., Ong, L., Foo, R., Chai, S. C., Fones, S., et al. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.869980 · Cited by 16

Endocrine causes of hypertension: literature review and practical approach

de Fréminville, J.-B., Amar, L., Azizi, M., & Mallart-Riancho, J. (2023) · Hypertension Research · doi:10.1038/s41440-023-01461-1 · Cited by 17

Mineralocorticoid and Apparent Mineralocorticoid Syndromes of Secondary Hypertension

Ardhanari, S., Kannuswamy, R., Chaudhary, K. R., Lockette, W. E., & Whaley‐Connell, A. T. (2015) · Advances in Chronic Kidney Disease · doi:10.1053/j.ackd.2015.03.002 · Cited by 16

Relationship of Ocular Microcirculation, Measured by Laser Speckle Flowgraphy, and Silent Brain Infarction in Primary Aldosteronism

Kunikata, H., Aizawa, N., Kudo, M., Mugikura, S., Nitta, F., Morimoto, R., Iwakura, Y., Ono, Y., Satoh, F., Takahashi, H., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0117452 · Cited by 16

Performance of the unilateral AV/IVC index in primary hyperaldosteronism subtype prediction: A validation study in a single tertiary centre

Suntornlohanakul, O., Soonthornpun, S., Srisintorn, W., Murray, R. D., & Kietsiriroje, N. (2020) · Clinical Endocrinology · doi:10.1111/cen.14210 · Cited by 16

Spironolactone in cardiovascular disease: an expanding universe?

Funder, J. W. (2017) · F1000Research · doi:10.12688/f1000research.11887.1 · Cited by 16

Mineralocorticoid Receptor Antagonists in Primary Aldosteronism

Stavropoulos, K., Papadopoulos, C. E., Koutsampasopoulos, K., Lales, G., Mitas, C., & Doumas, M. N. (2019) · Current Pharmaceutical Design · doi:10.2174/1381612825666190311130138 · Cited by 16

Aldosterone-Related Cardiovascular Disease and Benefits of Mineralocorticoid Receptor Antagonists in Clinical Practice

Alfarano, M., Marchionni, G., Costantino, J., Ballatore, F., Verardo, R., Miraldi, F., Ciciarello, F., Petramala, L., Letizia, C., Frustaci, A., et al. (2025) · JACC Advances · doi:10.1016/j.jacadv.2025.101762 · Cited by 18

A combination of laparoscopic approach and ERAS pathway optimizes outcomes and cost for adrenalectomy

He, Z., Chen, S., Lü, M., Luo, Y., Liu, T., Xiao, Y., & Wang, X. (2021) · Updates in Surgery · doi:10.1007/s13304-021-01188-z · Cited by 15

Risk of dementia in primary aldosteronism compared with essential hypertension: a nationwide cohort study

Hong, N., Kim, K. J., Yu, M. H., Jeong, S. H., Lee, S., Lim, J. S., & Rhee, Y. (2023) · Alzheimer s Research & Therapy · doi:10.1186/s13195-023-01274-x · Cited by 16

CMR-Verified Myocardial Fibrosis Is Associated With Subclinical Diastolic Dysfunction in Primary Aldosteronism Patients

Zhou, F., Wu, T., Wang, W., Cheng, W., Wan, S., Tian, H., Chen, T., Sun, J., & Ren, Y. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.672557 · Cited by 15

Predictors of confirmatory test results for the diagnosis of primary hyperaldosteronism in hypertensive patients with an aldosterone-to-renin ratio greater than 20. The SHRIMP study

Okamoto, R., Taniguchi, M., Onishi, Y., Kumagai, N., Uraki, J., Fujimoto, N., Fujii, E., Yano, Y., Ogura, T., & Ito, M. (2018) · Hypertension Research · doi:10.1038/s41440-018-0126-1 · Cited by 15

Primary Aldosteronism: Where Are We Now? Where to from Here?

Funder, J. W. (2020) · Hormone and Metabolic Research · doi:10.1055/a-1120-8623 · Cited by 15

Pathophysiology, Diagnosis, and Treatment of Mineralocorticoid Disorders

Magill, S. B. (2014) · Comprehensive physiology · doi:10.1002/cphy.c130042 · Cited by 15

Subclinical Primary Aldosteronism Is Characterized by Maladaptive Natriuretic Peptide and Adrenal Hormonal Physiology

Salle, S. P., Brown, J. M., Mahrokhian, S., Hanna, I., Honzel, B., Tsai, L. C., Newman, A. J., Wang, T. J., & Vaidya, A. (2025) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaf129 · Cited by 14

Target organ damage in untreated hypertensive patients with primary aldosteronism

Li, S., Huang, J., Zhu, C., Ng, M., Lin, Q., Wu, M., Liu, M., Wang, R., Cao, G., Chen, C., et al. (2024) · Journal of Clinical Hypertension · doi:10.1111/jch.14794 · Cited by 13

Cardiac Dysfunction in Association with Increased Inflammatory Markers in Primary Aldosteronism

Lim, J. S., Park, S., Park, S. I., Oh, Y. T., Choi, E. H., Kim, J., & Rhee, Y. (2016) · Endocrinology and Metabolism · doi:10.3803/enm.2016.31.4.567 · Cited by 14

Clinical Utility of the Adrenocorticotropin Stimulation Test with/without Dexamethasone Suppression for Definitive and Subtype Diagnosis of Primary Aldosteronism

Inoue, K., Omura, M., Sugisawa, C., Tsurutani, Y., Saito, J., & Nishikawa, T. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18050948 · Cited by 14

Retinoic acid receptor α as a novel contributor to adrenal cortex structure and function through interactions with Wnt and Vegfa signalling

Zein, R. M. E., Soria, A. H., Dzib, J. F. G., Rickard, A. J., Fernandes-Rosa, F. L., Samson-Couterie, B., Giscos-Douriez, I., Rocha, A., Poglitsch, M., Gómez-Sánchez, C. E., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-50988-2 · Cited by 14

Angiotensin II Type 1 Receptor Autoantibodies in Primary Aldosteronism

Meyer, L. S., Gong, S., Reincke, M., & Williams, T. A. (2020) · Hormone and Metabolic Research · doi:10.1055/a-1120-8647 · Cited by 16

Differences in Glycemic Abnormalities Between Primary Aldosteronism and Essential Hypertension: A Systematic Review and Meta-Analysis

Manosroi, W., Atthakomol, P., Watanawittawas, P., & Buranapin, S. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.870047 · Cited by 14

Microvascular endothelial function is impaired in patients with idiopathic hyperaldosteronism

Kishimoto, S., Matsumoto, T., Oki, K., Maruhashi, T., Kajikawa, M., Matsui, S., Hashimoto, H., Kihara, Y., Yusoff, F. M., & Higashi, Y. (2018) · Hypertension Research · doi:10.1038/s41440-018-0093-6 · Cited by 14

Stroke Risks in Primary Aldosteronism with Different Treatments: A Systematic Review and Meta-Analysis

Qian, N., Xu, J., & Wang, Y. (2022) · Journal of Cardiovascular Development and Disease · doi:10.3390/jcdd9090300 · Cited by 13

Hyperaldosteronism and cardiovascular risk in patients with autosomal dominant polycystic kidney disease

Lai, S., Petramala, L., Mastroluca, D., Petraglia, E., Gaeta, A. D., Indino, E. L., Panebianco, V., Ciccariello, M., Shahabadi, H., Galani, A., et al. (2016) · Medicine · doi:10.1097/md.0000000000004175 · Cited by 13

Genetic and epigenetic analyses of aldosterone-producing adenoma with hypercortisolemia

Kometani, M., Yoneda, T., Demura, M., Aono, D., Gondoh, Y., Karashima, S., Nishimoto, K., Yasuda, M., Horike, S., & Takeda, Y. (2019) · Steroids · doi:10.1016/j.steroids.2019.108470 · Cited by 13

Age-stratified comparison of clinical outcomes between medical and surgical treatments in patients with unilateral primary aldosteronism

Nakamaru, R., Yamamoto, K. I., Akasaka, H., Rakugi, H., Kurihara, I., Yoneda, T., Ichijo, T., Katabami, T., Tsuiki, M., Wada, N., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-86290-3 · Cited by 12

Accurate Location of Catheter Tip With the Free-to-Total Metanephrine Ratio During Adrenal Vein Sampling

Christou, F., Pivin, E., Denys, A. L., Abid, K., Zingg, T., Matter, M., Péchère-Bertschi, A., Maillard, M. P., Grouzmann, E., & Wuerzner, G. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.842968 · Cited by 13

Aldosterone/direct renin concentration ratio as a screening test for primary aldosteronism: a systematic review and meta-analysis

Gao, H., Luo, R., Jindie, L., & Tian, H. (2022) · Annals of Translational Medicine · doi:10.21037/atm-22-2272 · Cited by 13

Treatment of primary aldosteronism: Clinical practice guidelines of the Taiwan Society of Aldosteronism

Tseng, C., Chan, C., Lee, H.-Y., Pan, C., Peng, K., Wang, S., Huang, K., Tsai, Y., Wu, V., & Chueh, S. (2023) · Journal of the Formosan Medical Association · doi:10.1016/j.jfma.2023.05.032 · Cited by 13

Risk of ischemic stroke in primary aldosteronism patients.

Kao, C., Wu, C.-H., Lin, Y.-H., Chang, C.-C., Chen, H.-H., Wu, M.-S., Wu, V., & Wu, K.-D. (2015) · Clinica chimica acta; international journal of clinical chemistry · doi:10.1016/j.cca.2014.08.007 · Cited by 14

Salt, Aldosterone, and Parathyroid Hormone: What Is the Relevance for Organ Damage?

Catena, C., Colussi, G., Brosolo, G., Bertin, N., Novello, M., Palomba, A., & Sechi, L. A. (2017) · International Journal of Endocrinology · doi:10.1155/2017/4397028 · Cited by 13

Historical changes and between-facility differences in adrenal venous sampling for primary aldosteronism in Japan

JPAS Study Group, Fujii, Y., Takeda, Y., Kurihara, I., Itoh, H., Katabami, T., Ichijo, T., Wada, N., Shibayama, Y., Yoshimoto, T., et al. (2019) · Journal of Human Hypertension · doi:10.1038/s41371-019-0229-4 · Cited by 13

A clinical prediction score using age at diagnosis and saline infusion test parameters can predict aldosterone-producing adenoma from idiopathic adrenal hyperplasia

Leung, H., Woo, Y. C., Fong, C. H.-Y., Tan, K. C. B., Lau, E., Chan, K. W., & Leung, J. Y. (2019) · Journal of Endocrinological Investigation · doi:10.1007/s40618-019-01114-6 · Cited by 13

Diagnostic Accuracy of Aldosterone and Renin Measurement by Chemiluminescence for Screening of Patients with Primary Aldosteronism

Tetti, M., Burrello, J., Goi, J., Parasiliti‐Caprino, M., Gioiello, G., Settanni, F., Monticone, S., Mulatero, P., & Mengozzi, G. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25158453 · Cited by 12

Clinical presentation and surgical outcomes in primary aldosteronism differ by race

Gershuni, V. M., Ermer, J. P., Kelz, R. R., Roses, R. E., Cohen, D. L., Trerotola, S. O., Fraker, D. L., & Wachtel, H. (2019) · Journal of Surgical Oncology · doi:10.1002/jso.25806 · Cited by 12

Case report: Percutaneous adrenal arterial embolization cures resistant hypertension

Zhou, Y., Wang, D., Liu, Q., Hou, J., & Wang, P. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.1013426 · Cited by 12

Aldosterone Excess and Resistant Hypertension: Investigation and Treatment

Stowasser, M. (2014) · Current Hypertension Reports · doi:10.1007/s11906-014-0439-7 · Cited by 12

Electrical and Myocardial Remodeling in Primary Aldosteronism

Curione, M., Petramala, L., Savoriti, C., Verrenti, M., Baiocco, E., Salvatore, S., Zinnamosca, L., Iannucci, G., Sciomer, S., & Letizia, C. (2014) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2014.00007 · Cited by 12

ATP1A1 Mutant in Aldosterone-Producing Adenoma Leads to Cell Proliferation

Kobuke, K., Oki, K., Gómez-Sánchez, C. E., Gómez-Sánchez, E. P., Itcho, K., Ohno, H., Nagano, G., Yoshii, Y., Baba, R., Kodama, T., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222010981 · Cited by 13

Aldosterone testing: evaluation of a novel automated immunoassay

Derlet, F., Lepoutre, T., & Gruson, D. (2013) · Biomarkers · doi:10.3109/1354750x.2013.865276 · Cited by 12

Predictors of successful outcome after adrenalectomy for unilateral primary aldosteronism

Saadi, A., Bedoui, M. A., Zaghbib, S., Boussaffa, H., Mokaddem, S., Nacef, I. B., Ayed, H., Derouiche, A., Khiari, K., Chakroun, M., et al. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1205988 · Cited by 11

Captopril challenge test: an underutilized test in the diagnosis of primary aldosteronism

Jahan, S., Yang, J., Hu, J., Li, Q., & Fuller, P. J. (2024) · Endocrine Connections · doi:10.1530/ec-23-0445 · Cited by 11

Vitamin D–Parathyroid Hormone–Fibroblast Growth Factor 23 Axis and Cardiac Remodeling

Deng, C., & Wu, Y. (2024) · American Journal of Cardiovascular Drugs · doi:10.1007/s40256-024-00688-8 · Cited by 11

Pentraxin 3 as a New Cardiovascular Marker in Adrenal Adenomas

Kızılgül, M., Beysel, S., Özçelik, Ö., Kan, S., Apaydın, M., Çalişkan, M., Uçan, B., Sencar, M. E., Özdemir, Ş., & Çakal, E. (2017) · Endocrine Practice · doi:10.4158/ep161713.or · Cited by 11

A Comparison of Adrenalectomy and Eplerenone on Vascular Function in Patients with Aldosterone-producing Adenoma

Kishimoto, S., Oki, K., Maruhashi, T., Kajikawa, M., Hashimoto, H., Takaeko, Y., Harada, T., Yamaji, T., Han, Y., Kihara, Y., et al. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa561 · Cited by 11

Limited diagnostic utility of partially successful adrenal vein sampling for primary aldosteronism subtyping

Kocjan, T., Vidmar, G., Vrckovnik, R., & Stankovič, M. (2021) · Endokrynologia Polska · doi:10.5603/ep.a2021.0030 · Cited by 11

Best Practices: Indications and Procedural Controversies of Adrenal Vein Sampling for Primary Aldosteronism

Quencer, K. B., Singh, A., & Sharma, A. R. (2022) · American Journal of Roentgenology · doi:10.2214/ajr.22.27692 · Cited by 11

Primary Aldosteronism: Novel Insights

Stavropoulos, K., Imprialos, K. P., Papademetriou, V., Faselis, C. J., Tsioufis, K., Dimitriadis, K. S., & Doumas, M. N. (2019) · Current Hypertension Reviews · doi:10.2174/1573402115666190415155512 · Cited by 11

Assessment of skin microcirculation in primary aldosteronism: impaired microvascular responses compared to essential hypertensives and normotensives

Gkaliagkousi, Ε., Lazaridis, A. A., Anyfanti, P., Stavropoulos, K., Imprialos, K. P., Triantafyllou, Α., Mastrogiannis, Κ., Δούμα, Σ., & Doumas, M. N. (2021) · Journal of Human Hypertension · doi:10.1038/s41371-021-00639-9 · Cited by 11

How to Explore an Endocrine Cause of Hypertension

de Fréminville, J.-B., & Amar, L. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11020420 · Cited by 10

Re-Assessment of the Oral Salt Loading Test Using a New Chemiluminescent Enzyme Immunoassay Based on a Two-Step Sandwich Method to Measure 24-Hour Urine Aldosterone Excretion

Ozeki, Y., Kinoshita, M., Miyamoto, S., Yoshida, Y., Okamoto, M., Gotoh, K., Masaki, T., Kambara, K., & Shibata, H. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.859347 · Cited by 11

Antihypertensive Effects of Esaxerenone in Older Patients with Primary Aldosteronism

Fujimoto, M., Watanabe, S., Igarashi, K., Ruike, Y., Ishiwata, K., Naito, K., Ishida, A., Koshizaka, M., Suzuki, S., Shiko, Y., et al. (2023) · International Journal of Hypertension · doi:10.1155/2023/6453933 · Cited by 10

Bilateral adrenal artery embolization for the treatment of idiopathic hyperaldosteronism: A proof-of-principle single center study

Ji, G., Yang, C., Hou, J., Zhou, Y., Luo, T., Yang, Y., Wang, D., Liu, S., Wan, J., He, G., et al. (2024) · Hypertension Research · doi:10.1038/s41440-024-01897-z · Cited by 10

Integration of clinical parameters and CT-based radiomics improves machine learning assisted subtyping of primary hyperaldosteronism

Mansour, N., Mittermeier, A., Walter, R., Schachtner, B. M., Rudolph, J., Erber, B. M., Schmidt, V. F., Heinrich, D. A., Brüdgam, D., Tschaidse, L., et al. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1244342 · Cited by 10

Larger ascending aorta in primary aldosteronism: a 3-year prospective evaluation of adrenalectomy vs. medical treatment

Zavatta, G., Dalmazi, G. D., Pizzi, C., Bracchetti, G., Mosconi, C., Balacchi, C., Pagotto, U., & Vicennati, V. (2018) · Endocrine · doi:10.1007/s12020-018-1801-3 · Cited by 10

Obesity predicts persistence of resistant hypertension after surgery in patients with primary aldosteronism

Nakamaru, R., Yamamoto, K. I., Rakugi, H., Akasaka, H., Kurihara, I., Ichijo, T., Takeda, Y., Katabami, T., Tsuiki, M., Wada, N., et al. (2020) · Clinical Endocrinology · doi:10.1111/cen.14203 · Cited by 10

Diagnostic value of aldosterone to renin ratio calculated by plasma renin activity or plasma renin concentration in primary aldosteronism: a meta-analysis

Liu, Z., Deng, X., Luo, L., Li, S., Li, M., Deng, Q., Zhong, W., & Luo, Q. (2021) · Chinese Medical Journal · doi:10.1097/cm9.0000000000001906 · Cited by 10

Aldosterone: a cardiometabolic risk hormone?

Pereira, P. F., Priore, S. E., & Bressan, J. (2014) · PubMed · doi:10.3305/nh.2014.30.6.7725 · Cited by 11

Body mass index and contralateral ratio predict outcome following unilateral adrenalectomy in primary aldosteronism

Bokuda, K., Yatabe, M., Mizuguchi, Y., Niiyama, M., Seki, Y., Watanabe, D., Yatabe, J., Ando, T., Morimoto, S., & Ichihara, A. (2017) · Hypertension Research · doi:10.1038/hr.2017.78 · Cited by 10

Hypertension artérielle d’origine surrénale : reconnaître, évaluer et prendre en charge

Amar, L., Lorthioir, A., Giavarini, A., Plouin, P., & Azizi, M. (2014) · La Presse Médicale · doi:10.1016/j.lpm.2013.06.032 · Cited by 9

Esaxerenone Blocks Vascular Endothelial Inflammation Through SGK1

Yamamoto, H., Yoshida, N., & Kihara, S. (2022) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000001316 · Cited by 9

Epidemiology and diagnosis of primary aldosteronism. What have we learned from the SPAIN-ALDO registry?

Castro, M. A., Corrales, E. P., Rojas, P. M., & Ramírez, P. A. P. (2023) · Endocrine · doi:10.1007/s12020-023-03573-7 · Cited by 9

Clinical Practice Guideline for Management of Primary Aldosteronism: What is New in the 2016 Update?

Romero, D. G. (2016) · International Journal of Endocrinology and Metabolic Disorders · doi:10.16966/2380-548x.129 · Cited by 9

Diagnosing and Managing Primary Aldosteronism in Hypertensive Patients: a Case-Based Approach

Carey, R. M. (2016) · Current Cardiology Reports · doi:10.1007/s11886-016-0774-1 · Cited by 9

Diagnosis of primary aldosteronism in the hypertension specialist centers in Italy: a national survey

on behalf of the Young Investigator Group of the Italian Hypertension Society (Società Italiana dell’Ipertensione Arteriosa), Pucci, G., Monticone, S., Rosei, C. A., Balbi, G., Bertacchini, F., Ragazzo, F., Saladini, F., & Pengo, M. F. (2018) · Journal of Human Hypertension · doi:10.1038/s41371-018-0094-6 · Cited by 9

Taiwan mini-frontier of primary aldosteronism: Updating detection and diagnosis

Chang, C., Chen, Y., Lai, T., Zeng, Y.-H., Chen, C.-K., Tu, K., Lu, C., Wu, V., & Er, L. (2020) · Journal of the Formosan Medical Association · doi:10.1016/j.jfma.2020.08.001 · Cited by 9

Primary Aldosteronism and Ischemic Heart Disease

Patil, S. P., Rojulpote, C., & Amanullah, A. M. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.882330 · Cited by 9

Somatic mutations of the ATP1A1 gene and aldosterone-producing adenomas

Gómez-Sánchez, C. E., Kuppusamy, M., & Gómez-Sánchez, E. P. (2014) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2014.12.004 · Cited by 9

Aldosterone to Renin Ratio as a Screening Instrument for Primary Aldosteronism in a Middle-Aged Population with Atrial Fibrillation

Mourtzinis, G., Ebrahimi, A., Gustafsson, H., Johannsson, G., & Manhem, K. (2017) · Hormone and Metabolic Research · doi:10.1055/s-0043-119220 · Cited by 9

Primary aldosteronism in a general population sample. The Czech post-MONICA study

Widimsky, J., Jr., Bruthans, J., Wohlfahrt, P., Krajčoviechová, A., Šulc, P., Linhart, A., Filipovský, J., Lánská, V., & Cífková, R. (2020) · Blood Pressure · doi:10.1080/08037051.2020.1723406 · Cited by 8

Lymphatic vessels and the renin-angiotensin-system

Bertoldi, G., Caputo, I., Calò, L. A., & Rossitto, G. (2023) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00023.2023 · Cited by 8

The relationship among cardiac structure, dietary salt and aldosterone in patients with primary aldosteronism

Hung, C., the TAIPAI Study Group, Wu, X.-M., Chen, C., Chen, Y.-H., Wu, V., Liao, C., Chang, Y., Yen, R., Lu, C., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.17505 · Cited by 8

Challenges in obesity and primary aldosteronism: Diagnosis and treatment

Gershuni, V. M., Herman, D. S., Kelz, R. R., Roses, R. E., Cohen, D. L., Trerotola, S. O., Fraker, D. L., & Wachtel, H. (2019) · Surgery · doi:10.1016/j.surg.2019.03.036 · Cited by 8

Effect of long‐term glucocorticoid therapy on cardiac functions in children with congenital adrenal hyperplasia

Amr, N. H., Mahmoud, R. A. A., Youssef, O., Toaima, N. N., & Elsedfy, H. H. (2020) · Clinical Endocrinology · doi:10.1111/cen.14333 · Cited by 8

Prevalence of Primary Aldosteronism Across the Stages of Hypertension Based on a New Combined Overnight Test

Voulgaris, N., Tyfoxylou, E., Vlachou, S., Kyriazi, E., Gravvanis, C., Kapsali, C., Markou, Α., Papanastasiou, L., Gryparis, A., Kassi, E. N., et al. (2021) · Hormone and Metabolic Research · doi:10.1055/a-1507-5226 · Cited by 8

Subtype Diagnosis of Primary Aldosteronism: Approach to Different Clinical Scenarios

Burrello, J., Monticone, S., Tetti, M., Rossato, D., Versace, K., Castellano, I., Williams, T. A., Veglio, F., & Mulatero, P. (2015) · Hormone and Metabolic Research · doi:10.1055/s-0035-1565089 · Cited by 8

Clinical Characteristics and Long-Term Outcome of Primary Aldosteronism in a Norwegian Population

Grytaas, M. A., Strømsøy, S., Rørvik, J. T., Arnes, J. B., Heie, A., Arnesen, T., Jørstad, M. D., Nedrebø, B. G., Jøssang, D. E., Jensen, D., et al. (2017) · Hormone and Metabolic Research · doi:10.1055/s-0043-118909 · Cited by 7

Molecular mechanisms in primary aldosteronism

Sousa, K. D., Abdellatif, A. B., Zein, R. M. E., & Zennaro, M. (2019) · Journal of Endocrinology · doi:10.1530/joe-19-0193 · Cited by 8

Adrenal Vein Sampling in a Patient With Primary Hyperaldosteronism and Severe Contrast Allergy

Prins, M. L. M., Ballieux, B. E. P. B., Meijer, O. C., Pereira, A. M., & Nijhoff, M. F. (2021) · Journal of the Endocrine Society · doi:10.1210/jendso/bvab122 · Cited by 8

Concurrence of overt Cushing’s syndrome and primary aldosteronism accompanied by aldosterone-producing cell cluster in adjacent adrenal cortex: case report

Fushimi, Y., Tatsumi, F., Sanada, J., Shimoda, M., Kamei, S., Nakanishi, S., Kaku, K., Mune, T., & Kaneto, H. (2021) · BMC Endocrine Disorders · doi:10.1186/s12902-021-00818-2 · Cited by 8

Saline Infusion Test highly associated with the incidence of cardio- and cerebrovascular events in primary aldosteronism

Hayashi, R., Tamada, D., Murata, M., Mukai, K., Kitamura, T., Otsuki, M., & Shimomura, I. (2017) · Endocrine Journal · doi:10.1507/endocrj.ej16-0337 · Cited by 7

Machine learning approach to predict subtypes of primary aldosteronism is helpful to estimate indication of adrenal vein sampling

Tamaru, S., Suwanai, H., Abe, H., Sasaki, J., Ishii, K., Iwasaki, H., Shikuma, J., Ito, R., Miwa, T., Sasaki, T., et al. (2022) · High Blood Pressure & Cardiovascular Prevention · doi:10.1007/s40292-022-00523-8 · Cited by 7

Mineralocorticoid replacement therapy in salt‐wasting congenital adrenal hyperplasia

Lang, K., Quinkler, M. O., & Kienitz, T. (2023) · Clinical Endocrinology · doi:10.1111/cen.14959 · Cited by 7

Homeobox A5 activates p53 pathway to inhibit proliferation and promote apoptosis of adrenocortical carcinoma cells by inducing Aldo-Keto reductase family 1 member B10 expression

Chen, D., Shen, Z., Cheng, X., Wang, Q., Zhou, J., Ren, F., Sun, Y., Wang, H., & Huang, R. (2021) · Bioengineered · doi:10.1080/21655979.2021.1924545 · Cited by 7

Diabetes mellitus is associated with more adverse non-hemodynamic left ventricular remodeling and less recovery in patients with primary aldosteronism

Chen, U.-L., Liao, C., Wang, S., Lai, T., Huang, K., Chang, C., Lee, B., Lu, C., Chang, Y., Chang, Y., et al. (2023) · Journal of Investigative Medicine · doi:10.1177/10815589221141840 · Cited by 7

Evaluation of various confirmatory tests for the diagnosis of aldosterone-producing adenoma

Kidoguchi, S., Sugano, N., Kawauchi, R., Nakashima, D., Hayashi-Ishikawa, N., Tokudome, G., & Yokoo, T. (2020) · Journal of the Renin-Angiotensin-Aldosterone System · doi:10.1177/1470320320919610 · Cited by 7

Comparisons of plasma aldosterone and renin data between an automated chemiluminescent immunoanalyzer and conventional radioimmunoassays in the screening and diagnosis of primary aldosteronism

Tamura, N., Watanabe, E., Shirakawa, R., Nakatani, E., Yamada, K., Hatakeyama, H., Torii-Hanakita, M., Kyo, C., Kosugi, R., Ogawa, T., et al. (2021) · PLoS ONE · doi:10.1371/journal.pone.0253807 · Cited by 7

Heart-Ankle Pulse Wave Velocity Is Superior to Brachial-Ankle Pulse Wave Velocity in Detecting Aldosterone-Induced Arterial Stiffness

Chen, Z., Pan, C., Tsai, C., Chang, Y., Chang, C., Lee, B., Chiu, Y., Huang, W., Lin, Y., Wu, V., et al. (2021) · Biomedicines · doi:10.3390/biomedicines9101285 · Cited by 7

Transvenous Radiofrequency Ablation of Adrenal Gland: Experimental Study

Sakakibara, H., Seiji, K., Oguro, S., Mori, K., Omata, K., Tezuka, Y., Ono, Y., Morimoto, R., Masuda, T., Miyamoto, H., et al. (2022) · CardioVascular and Interventional Radiology · doi:10.1007/s00270-022-03155-6 · Cited by 7

KCNJ5 mutation is a predictor for recovery of endothelial function after adrenalectomy in patients with aldosterone-producing adenoma

Kishimoto, S., Oki, K., Maruhashi, T., Kajikawa, M., Mizobuchi, A., Harada, T., Yamaji, T., Hashimoto, Y., Yoshimura, K., Nakano, Y., et al. (2023) · Hypertension Research · doi:10.1038/s41440-023-01375-y · Cited by 7

Efficacy and safety of medical treatment of primary aldosteronism: a real-world data study in Spain

Goi, J., Fano, M. P., Gellida, A. R., Boillos, M. G., Rojas‐Marcos, P. M., Guayerbas, L. C., Cano, A. M. G., Ruiz-Sánchez, J. G., Vicente, A., Hoyos, E. G., et al. (2025) · European Journal of Endocrinology · doi:10.1093/ejendo/lvaf158 · Cited by 7

Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism

Milliez, P., Girerd, X. J., Plouin, P., Blacher, J., Safar, M. E., & Mourad, J. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.01.015 · Cited by 1,541

CARDIOVASCULAR COMPLICATIONS IN PATIENTS WITH PRIMARY HYPERALDOSTERONISM: A CONTROLLED CROSS-SECTIONAL STUDY: PP.18.178

Steichen, O., Amar, L., & Plouin, P. (2010) · Journal of Hypertension · doi:10.1097/01.hjh.0000379104.38177.14 · Cited by 3

MON-213 Cardiac Damage and Related Risk Factors in Patients with Primary Aldosteronism

wang, W. (2020) · Journal of the Endocrine Society · doi:10.1210/jendso/bvaa046.1666

Cardiovascular risk in primary aldosteronism

Wu, X., Yu, J., & Tian, H. (2019) · Medicine · doi:10.1097/md.0000000000015985 · Cited by 44

CARDIOVASCULAR EVENTS AND TARGET ORGAN DAMAGE IN PRIMARY ALDOSTERONISM

Monticone, S., D’Ascenzo, F., Moretti, C., Williams, T. A., Veglio, F., Gaïta, F., & Mulatero, P. (2018) · Journal of Hypertension · doi:10.1097/01.hjh.0000539344.30377.17